Betta Pharmaceuticals Co., Ltd. 300558.SZ Stock
Betta Pharmaceuticals Co., Ltd. Price Chart
Betta Pharmaceuticals Co., Ltd. 300558.SZ Financial and Trading Overview
| Betta Pharmaceuticals Co., Ltd. stock price | 37.65 CNY |
| Previous Close | 48.56 CNY |
| Open | 48.85 CNY |
| Bid | 48.48 CNY x 0 |
| Ask | 48.5 CNY x 0 |
| Day's Range | 48.03 - 49.05 CNY |
| 52 Week Range | 39.54 - 74.83 CNY |
| Volume | 3.72M CNY |
| Avg. Volume | 5.42M CNY |
| Market Cap | 20.26B CNY |
| Beta (5Y Monthly) | 0.782534 |
| PE Ratio (TTM) | 179.77777 |
| EPS (TTM) | 0.83 CNY |
| Forward Dividend & Yield | 0.07 (0.13%) |
| Ex-Dividend Date | June 15, 2023 |
| 1y Target Est | 67.8 CNY |
300558.SZ Valuation Measures
| Enterprise Value | 21.81B CNY |
| Trailing P/E | 179.77777 |
| Forward P/E | 40.115704 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.721101 |
| Price/Book (mrq) | 4.1409316 |
| Enterprise Value/Revenue | 9.385 |
| Enterprise Value/EBITDA | 64.978 |
Trading Information
Betta Pharmaceuticals Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.782534 |
| 52-Week Change | -13.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 74.83 CNY |
| 52 Week Low | 39.54 CNY |
| 50-Day Moving Average | 63.58 CNY |
| 200-Day Moving Average | 55.02 CNY |
300558.SZ Share Statistics
| Avg. Volume (3 month) | 5.42M CNY |
| Avg. Daily Volume (10-Days) | 6.49M CNY |
| Shares Outstanding | 417.47M |
| Float | 223.94M |
| Short Ratio | N/A |
| % Held by Insiders | 50.32% |
| % Held by Institutions | 15.11% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.07 |
| Trailing Annual Dividend Yield | 0.14% |
| 5 Year Average Dividend Yield | 33.00% |
| Payout Ratio | 0.9259 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4.86% |
| Operating Margin (ttm) | 2.99% |
| Gross Margin | 88.09% |
| EBITDA Margin | 14.44% |
Management Effectiveness
| Return on Assets (ttm) | 0.59% |
| Return on Equity (ttm) | 1.90% |
Income Statement
| Revenue (ttm) | 2.32B CNY |
| Revenue Per Share (ttm) | 5.56 CNY |
| Quarterly Revenue Growth (yoy) | -9.099% |
| Gross Profit (ttm) | N/A |
| EBITDA | 335.61M CNY |
| Net Income Avi to Common (ttm) | 113.14M CNY |
| Diluted EPS (ttm) | 0.27 |
| Quarterly Earnings Growth (yoy) | -38.60% |
Balance Sheet
| Total Cash (mrq) | 584.97M CNY |
| Total Cash Per Share (mrq) | 1.4 CNY |
| Total Debt (mrq) | 2.02B CNY |
| Total Debt/Equity (mrq) | 40.32 CNY |
| Current Ratio (mrq) | 1.327 |
| Book Value Per Share (mrq) | 11.722 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 415.46M CNY |
| Levered Free Cash Flow (ttm) | -690433472 CNY |
Profile of Betta Pharmaceuticals Co., Ltd.
| Country | China |
| State | N/A |
| City | Hangzhou |
| Address | No. 355, Xingzhong Road |
| ZIP | N/A |
| Phone | 86 571 8613 0357 |
| Website | https://www.bettapharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1961 |
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.
Q&A For Betta Pharmaceuticals Co., Ltd. Stock
What is a current 300558.SZ stock price?
Betta Pharmaceuticals Co., Ltd. 300558.SZ stock price today per share is 37.65 CNY.
How to purchase Betta Pharmaceuticals Co., Ltd. stock?
You can buy 300558.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Betta Pharmaceuticals Co., Ltd.?
The stock symbol or ticker of Betta Pharmaceuticals Co., Ltd. is 300558.SZ.
Which industry does the Betta Pharmaceuticals Co., Ltd. company belong to?
The Betta Pharmaceuticals Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Betta Pharmaceuticals Co., Ltd. have in circulation?
The max supply of Betta Pharmaceuticals Co., Ltd. shares is 418.49M.
What is Betta Pharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Betta Pharmaceuticals Co., Ltd. PE Ratio is 45.36145000 now.
What was Betta Pharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Betta Pharmaceuticals Co., Ltd. EPS is 0.83 CNY over the trailing 12 months.
Which sector does the Betta Pharmaceuticals Co., Ltd. company belong to?
The Betta Pharmaceuticals Co., Ltd. sector is Healthcare.